Vera Therapeutics, Inc. Business Finance Contracts & Agreements
14 Contracts & Agreements
- Investor Rights Agreements (1 contract)
- Loan Agreements (2)
- Purchase Agreements (1)
- Stock Agreements (6)
- Underwriting Agreements (4)
- Form of Restricted Stock Unit Grant Notice and Award Agreement under the Vera Therapeutics, Inc. 2024 Inducement Plan (Filed With SEC on March 27, 2024)
- Forms of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the Vera Therapeutics, Inc. 2024 Inducement Plan (Filed With SEC on March 27, 2024)
- Description of Common Stock of the Registrant (Filed With SEC on March 27, 2024)
- Underwriting Agreement by and among the Company, J.P. Morgan Securities LLC, Cowen and Company, LLC and Evercore Group L.L.C., dated January 29, 2024 (Filed With SEC on January 30, 2024)
- Underwriting Agreement by and among the Company, J.P. Morgan Securities LLC, Cowen and Company, LLC and Evercore Group L.L.C., dated February 1, 2023 (Filed With SEC on February 2, 2023)
- First Amendment to Loan and Security Agreement, by and between the Registrant and Oxford Finance, LLC, dated November 4, 2022 (Filed With SEC on November 9, 2022)
- Description of Common Stock of the Registrant (Filed With SEC on March 28, 2022)
- Asset Purchase Agreement between the Registrant and Amplyx Pharmaceuticals, Inc. dated December 16, 2021 (Filed With SEC on February 7, 2022)
- Loan and Security Agreement between the Registrant and Oxford Finance LLC, dated December 17, 2021 (Filed With SEC on February 7, 2022)
- Form of Underwriting Agreement (Filed With SEC on February 7, 2022)
- Vera Therapeutics, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on May 10, 2021)
- Form of Class A Common Stock Certificate (Filed With SEC on May 10, 2021)
- Form of Underwriting Agreement (Filed With SEC on May 10, 2021)
- Second Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated October 29, 2020 (Filed With SEC on April 23, 2021)
